Observational studyAlzheimer's & dementia : the journal of the Alzheimer's Association2025
Identifying subphenotypes of patients undergoing post-operative delirium assessment.
Observational study in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Perioperative neurofilament light chain and glial fibrillary acidic protein as biomarkers of postoperative delirium: a systematic review and meta-analysis.BMC geriatrics · 2026Pooled it
- Delirium and Iatrogenic Withdrawal Profiles in the Pediatric Intensive Care Unit (PICU): A Latent Profile Analysis of Nurse-Administered Bedside Scales.Journal of clinical medicine · 2026Article
- Association between the preoperative stress hyperglycemia ratio and postoperative delirium in older adults undergoing non-cardiac surgery: a retrospective cohort study.European geriatric medicine · 2026Article
- Identifying subphenotypes of patients undergoing post-operative delirium assessment.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
introductionDelirium has heterogeneous etiologies and clinical presentations and is often associated with poor outcomes. Its pathophysiological mechanisms remain largely hypothetical and without targeted pharmacological treatment. This work investigates subphenotypes of patients undergoing delirium assessment based on clinical features and fluid biomarkers.
methodsWe performed latent class analysis of an observational cohort of older adults undergoing elective surgery.
resultsTwo classes were identified, both containing individuals experiencing delirium symptoms, with a higher number in Class 1 (p < 0.001). Class 1 were older, less educated, and had more depression (p < 0.001). They performed worse in all pre-operative cognitive assessments (p < 0.001) and had more markers of central nervous system damage: cerebrospinal fluid glial fibrillary acidic protein, neurofilament light chain, and soluble triggering receptor expressed on myeloid cells 2 (p < 0.001); plasma phosphorylated tau (p = 0.024); and amyloid beta 42/40 ratio (p < 0.001). Class 2 experienced more pain (p = 0.006) and received more morphine equivalents (p = 0.018). DISCUSSION: Delirium and neighboring phenotypes should be investigated thoroughly in the newly dawning era of precision medicine, to establish novel treatments. HIGHLIGHTS: Latent class analysis identified two subphenotypes of patients. Both groups contained patients with delirium or its individual symptoms. Groups differed by age, education, depression, independent living, and pain levels. Groups differed by pre-operative and post-operative cognition. Groups differed by biomarker levels of neurodegeneration and neuronal injury.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.